Principal Technologies PTEC.V · CAD

Its shares trade on TSX Venture under the ticker PTEC.V. It has been listed since 1 November 2018. In the fiscal year to 31 July 2025, it reported revenue of C$370,424 and a net loss of C$4.2m. At that date it held total assets of C$1.5m and shareholders' equity of C$89,609.

Principal Technologies, Inc. engages in the operations in healthcare technology including the project management of international scale clinical studies primarily related to medical device technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-01. The firm is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The company operates in one operational segment, being its operations in healthcare technology, including the project management of international scale clinical studies primarily related to medical device technologies. The firm's subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Gerald TrentChief Executive Officer, Director, since 2021C$176,506
• Mr. Peter MckeownChief Financial Officer, Corporate SecretaryC$36,325
• Dr. Leopold SpechtIndependent DirectorC$6,622
• Prince Alfred Von LiechtensteinIndependent DirectorC$9,933

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.